IART

IART

USD

Integra LifeSciences Holdings Corporation Common Stock

$11.300-0.090 (-0.790%)

Prix en Temps Réel

Healthcare
Dispositifs médicaux
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$11.390

Haut

$11.600

Bas

$11.220

Volume

0.19M

Fondamentaux de l'Entreprise

Capitalisation Boursière

880.2M

Industrie

Dispositifs médicaux

Pays

United States

Statistiques de Trading

Volume Moyen

1.22M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $11.05Actuel $11.300Haut $27.13

Actualités Connexes

Analyst Upgrades

Truist Securities Reiterates Hold on Integra Lifesciences, Lowers Price Target to $13

Truist Securities analyst Ravi Misra reiterates Integra Lifesciences with a Hold and lowers the price target from $15 to $13.

Voir plus
Truist Securities Reiterates Hold on Integra Lifesciences, Lowers Price Target to $13
Analyst Upgrades

Citigroup Maintains Sell on Integra Lifesciences, Lowers Price Target to $11

Citigroup analyst Joanne Wuensch maintains Integra Lifesciences with a Sell and lowers the price target from $12 to $11.

Voir plus
Citigroup Maintains Sell on Integra Lifesciences, Lowers Price Target to $11
Analyst Upgrades

JP Morgan Maintains Underweight on Integra Lifesciences, Raises Price Target to $13

JP Morgan analyst Robbie Marcus maintains Integra Lifesciences with a Underweight and raises the price target from $12 to $13.

Voir plus
JP Morgan Maintains Underweight on Integra Lifesciences, Raises Price Target to $13
GlobeNewswire

Integra LifeSciences Reports Third Quarter 2025 Financial Results

PRINCETON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today reported financial results for the third quarter ending

Voir plus
Integra LifeSciences Reports Third Quarter 2025 Financial Results